AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H209-H215, 2004. First published February 26, 2004; doi:10.1152/ajpheart.00946.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/H209    most recent
00946.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, B.
Right arrow Articles by Lesur, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, B.
Right arrow Articles by Lesur, O.

Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock

Bruno Levy,1,2 Chantal Vallée,1 Francois Lauzier,1 Gérard E. Plante,3 Arnaud Mansart,2 Jean-Pierre Mallie,2 and Olivier Lesur1,4

1Groupe de Recherche en Physiopathologie Respiratoire, 4Soins Intensifs Médicaux, and 3Laboratoire de Physiologie Rénale et Vasculaire, Institut de Pharmacologie, Université de Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4; and 2Laboratoire de Néphrologie Expérimentale, Faculté de Médecine, 54505 Vandoeuvre Les Nancy, France

Submitted 9 October 2003 ; accepted in final form 20 February 2004

Norepinephrine (NE), a standard of care, AVP, an alternative candidate, and L-canavanine (LC), a selective inhibitor of inducible nitric oxide synthase, were compared for efficacy and innocuousness on global and regional hemodynamics, plasmatic and tissue lactate-to-pyruvate ratio (L/P), tissue high-energy phosphates, renal function, and tissue capillary permeability in a rat model of endotoxic normokinetic shock. Mean arterial pressure (MAP) decreased (~35%) but aortic blood flow increased during endotoxin infusion (P < 0.05 vs. control). Additionally, there was a decrease in mesenteric (MBF) and renal (RBF) blood flows along with regional-to-systemic ratio (P < 0.05 vs. control). All tested drugs restored MAP to basal levels but slightly decreased abdominal aortic flow; however, RBF and MBF remained unchanged. Endotoxin significantly decreased diuresis and inulin clearance (~3- to 4-fold), whereas AVP or LC attenuated this drop (P < 0.05 vs. control). In contrast, NE did not improve endotoxin-induced renal dysfunction. Endotoxin induced gut and lung hyperpermeability (P < 0.05 vs. control). Endotoxin-induced gut hyperpermeability was inhibited by AVP, LC, and NE. Endotoxin-induced lung hyperpermeability was further worsened by NE (~2-fold increase) but not AVP infusion (P < 0.05 vs. endotoxin). LC significantly improved endotoxin-induced pulmonary hyperpermeability. Endotoxin increased renal lactate and decreased renal ATP. NE did not change renal lactate or renal ATP. AVP and LC decreased renal lactate and normalized renal ATP. Finally, endotoxin was associated with increased lactate levels and L/P (~2- and 1.5-fold increases vs. control, respectively), whereas AVP and LC, but not NE, normalized both parameters after endotoxin challenge. These results suggest that, in a short-term endotoxic shock model, AVP improves systemic hemodynamics without side effects and has particular beneficial effects on renal function.

septic shock; vascular permeability; renal function



Address for reprint requests and other correspondence: O. Lesur, Centre de Recherche Clinique, CHUS Sherbrooke, PQ, Canada J1H 5N4 (E-mail: olivier.lesur{at}USherbrooke.ca).




This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. L. M. Mitchell and J.M. Hunter
Vasopressin and its antagonists: what are their roles in acute medical care?
Br. J. Anaesth., August 1, 2007; 99(2): 154 - 158.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. A. Munger, R. C. Blantz, and M. J. Lortie
Acute renal response to LPS: impaired arginine production and inducible nitric oxide synthase activity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R684 - R691.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-J. Boffa and W. J. Arendshorst
Maintenance of Renal Vascular Reactivity Contributes to Acute Renal Failure during Endotoxemic Shock
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 117 - 124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.